2021
DOI: 10.1002/mdc3.13204
|View full text |Cite
|
Sign up to set email alerts
|

Determining the Validity of Conducting Rating Scales in Friedreich Ataxia through Video

Abstract: BackgroundBackground: The Friedreich Ataxia Rating Scale (FARS) and the Scale for the Assessment and Rating of Ataxia (SARA) are commonly used neurological rating scales in Friedreich ataxia (FRDA). The modified Friedreich Ataxia Rating Scale (mFARS) has been accepted as an appropriate outcome measure for clinical trials in FRDA. Objectives Objectives: The COVID-19 pandemic has resulted in limited face-to-face interactions with individuals involved in natural history studies and clinical trials. The aim of thi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
5
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(5 citation statements)
references
References 16 publications
0
5
0
Order By: Relevance
“…While the trial investigated a remote examination and non-FRDA ataxias, it nonetheless supports the idea that a score of a clinical examination is not as static as it might appear. In contrast, research seeking to quantify retest-reliability of the modified Friedreich Ataxia Rating Scale as well as the SARA in patients of FRDA did find rather high retest-reliability 37,38 . Despite standardised operating procedures effects due to multiple and changing examiners as well as shifts in subjective criteria where examinations depend on a clinician's rating are concerns over the long-term and ways to address these issues should be sought.…”
Section: Discussionmentioning
confidence: 86%
“…While the trial investigated a remote examination and non-FRDA ataxias, it nonetheless supports the idea that a score of a clinical examination is not as static as it might appear. In contrast, research seeking to quantify retest-reliability of the modified Friedreich Ataxia Rating Scale as well as the SARA in patients of FRDA did find rather high retest-reliability 37,38 . Despite standardised operating procedures effects due to multiple and changing examiners as well as shifts in subjective criteria where examinations depend on a clinician's rating are concerns over the long-term and ways to address these issues should be sought.…”
Section: Discussionmentioning
confidence: 86%
“…Demonstration of feasibility of SARA home recordings and comparability of self‐performed SARA scores at home to examinations by a physician in the clinic have already been conducted in smaller cohorts. 6 , 7 Moving an examination, or at least parts of it, to patient's home is not only well accepted, but it is also closer to patients’ daily life surroundings, easier to integrate in their daily life, and allows higher frequent sampling, which might in turn, allow a higher signal to noise ratio. 6 , 7 , 10 In addition, from the patient's perspective, home recordings reduce the burden of travel and risk of infection.…”
Section: Discussionmentioning
confidence: 99%
“… 6 , 7 Moving an examination, or at least parts of it, to patient's home is not only well accepted, but it is also closer to patients’ daily life surroundings, easier to integrate in their daily life, and allows higher frequent sampling, which might in turn, allow a higher signal to noise ratio. 6 , 7 , 10 In addition, from the patient's perspective, home recordings reduce the burden of travel and risk of infection. From the examiner's perspective, home recordings are resource efficient, and therefore, allow for a higher frequency of examinations, for example in the context of treatment surveillance and/or symptom fluctuation.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations